Literature DB >> 22171818

Management of pulmonary hypertension and Down syndrome.

P King1, R Tulloh.   

Abstract

Down syndrome (DS) is strongly associated with pulmonary hypertension, but there are many causes requiring a multi-disciplinary approach to the problem. Nearly half of children with DS have upper airway obstruction and the same proportion have congenital heart disease, both of which may cause pulmonary hypertension. Additional problems include pulmonary hypoplasia, structural lung disease and gastro-oesophageal reflux. It is no longer acceptable to ignore these symptoms as early treatment may be preventative.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22171818     DOI: 10.1111/j.1742-1241.2011.02823.x

Source DB:  PubMed          Journal:  Int J Clin Pract Suppl        ISSN: 1368-504X


  11 in total

Review 1.  Echocardiography in children with Down syndrome.

Authors:  Mohammed A Al-Biltagi
Journal:  World J Clin Pediatr       Date:  2013-11-08

2.  Risk factors with intravenous sedation for patients with disabilities.

Authors:  Fumihiro Yoshikawa; Yoh Tamaki; Hisa Okumura; Zenzo Miwa; Masaaki Ishikawa; Kazuhiro Shimoyama; Zenkou Nakamura; Hitomi Kunimori; Shigeharu Jinno; Hikaru Kohase; Haruhisa Fukayama
Journal:  Anesth Prog       Date:  2013

3.  A study to determine the prevalence of pulmonary arterial hypertension in children with Down syndrome and congenital heart disease.

Authors:  Mukti Sharma; Sanjeev Khera; Vishal Sondhi; Amit Devgan
Journal:  Med J Armed Forces India       Date:  2013-02-23

4.  Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.

Authors:  Katherine A Waugh; Paula Araya; Ahwan Pandey; Kimberly R Jordan; Keith P Smith; Ross E Granrath; Santosh Khanal; Eric T Butcher; Belinda Enriquez Estrada; Angela L Rachubinski; Jennifer A McWilliams; Ross Minter; Tiana Dimasi; Kelley L Colvin; Dmitry Baturin; Andrew T Pham; Matthew D Galbraith; Kyle W Bartsch; Michael E Yeager; Christopher C Porter; Kelly D Sullivan; Elena W Hsieh; Joaquin M Espinosa
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

5.  Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary.

Authors:  Maire E Percy; Walter J Lukiw
Journal:  Int J Dev Disabil       Date:  2017-04-09

6.  Prevalence of Congenital Heart Disease and Pulmonary Hypertension in Down's Syndrome: An Echocardiographic Study.

Authors:  Nilda Espinola-Zavaleta; María Elena Soto; Angel Romero-Gonzalez; Lidia Del Carmen Gómez-Puente; Luis Muñoz-Castellanos; Aasha S Gopal; Candace Keirns; Eulo Lupi-Herrera
Journal:  J Cardiovasc Ultrasound       Date:  2015-06-26

7.  Reversibility of Pulmonary Hypertension Following Surgical Atrial Septal Defect Closure in Children with Down Syndrome.

Authors:  Jue Seong Lee; Seul Gi Cha; Gi Beom Kim; Sang Yun Lee; Mi Kyoung Song; Hye Won Kwon; Eun Jung Bae; Jae Gun Kwak; Woong Han Kim; Jeong Ryul Lee
Journal:  J Cardiovasc Imaging       Date:  2019-10

Review 8.  When nature's robots go rogue: exploring protein homeostasis dysfunction and the implications for understanding human aging disease pathologies.

Authors:  Julie A Reisz; Alexander S Barrett; Travis Nemkov; Kirk C Hansen; Angelo D'Alessandro
Journal:  Expert Rev Proteomics       Date:  2018-03-21       Impact factor: 3.940

9.  Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension.

Authors:  Maurice Beghetti; Andrzej Rudzinski; Min Zhang
Journal:  BMC Cardiovasc Disord       Date:  2017-07-04       Impact factor: 2.298

10.  Opportunities, barriers, and recommendations in down syndrome research.

Authors:  James A Hendrix; Angelika Amon; Leonard Abbeduto; Stamatis Agiovlasitis; Tarek Alsaied; Heather A Anderson; Lisa J Bain; Nicole Baumer; Anita Bhattacharyya; Dusan Bogunovic; Kelly N Botteron; George Capone; Priya Chandan; Isabelle Chase; Brian Chicoine; Cécile Cieuta-Walti; Lara R DeRuisseau; Sophie Durand; Anna Esbensen; Juan Fortea; Sandra Giménez; Ann-Charlotte Granholm; Laura J Hahn; Elizabeth Head; Hampus Hillerstrom; Lisa M Jacola; Matthew P Janicki; Joan M Jasien; Angela R Kamer; Raymond D Kent; Bernard Khor; Jeanne B Lawrence; Catherine Lemonnier; Amy Feldman Lewanda; William Mobley; Paul E Moore; Linda Pollak Nelson; Nicolas M Oreskovic; Ricardo S Osorio; David Patterson; Sonja A Rasmussen; Roger H Reeves; Nancy Roizen; Stephanie Santoro; Stephanie L Sherman; Nasreen Talib; Ignacio E Tapia; Kyle M Walsh; Steven F Warren; A Nicole White; Guang William Wong; John S Yi
Journal:  Transl Sci Rare Dis       Date:  2021-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.